Company / SG&A Expense
Sensus Healthcare, Inc. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$7.1M
FY2025
5-year range
$4.0M / $7.1M
FY2021-FY2025
Trend
+38.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has increased for 4 consecutive years, from $4M in FY2021 to $7M in FY2025.
Based on SEC 10-K filings.
$7M in FY2025 with a 5-year CAGR of +12.3%.
Increased from $5M to $7M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +15.9%
- 5-Year CAGR
- +12.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- Sensus Healthcare, Inc.'s sg&a expense has grown for 4 consecutive years.
- 5-year CAGR of +12.3%, indicating consistent growth.
- In FY2025, sg&a expense increased 38.6% year-over-year.
- Lowest sg&a expense in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -6.59 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.1M | +38.6% |
| FY2024 | $5.2M | +3.0% |
| FY2023 | $5.0M | +9.0% |
| FY2022 | $4.6M | +15.2% |
| FY2021 | $4.0M | -0.4% |
| FY2020 | $4.0M | -2.9% |
| FY2019 | $4.1M | +10.8% |
| FY2018 | $3.7M | +7.3% |
| FY2017 | $3.5M | +118.7% |
| FY2016 | $1.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026